Warning letters, 483s, Recalls, Import Alerts, Audit observations
Vamorolone is a synthetic corticosteroid approved by USFDA for the treatment of Duchenne Muscular Dystrophy
USFDA 483 issued to UCB Farchim SA, Switzerland site (FEI 3005023799) is published by FDA.
FDA uses Remote Regulatory Assessments (RRAs) to assess compliance of facility with applicable laws and
Panacea Biotec, Baddi facility was inspected by USFDA in Oct 2023- investigators Sandra A Boyd
Nectar Lifesciences was issued an Untitled letter (UL) by USFDA in Sep 23 citing deficiencies
Baxter initiated recall of one lot of Doxil (doxorubicin hydrochloride liposome injection) in U.S due
Spectrum Laboratories Inc, New Jersey, USA (FEI 2246824) was inspected by FDA investigators Sayyem H
In a communique Biocon stated USFDA has categorised inspection classification for Biocon Malaysia as OAI
Velsipity (etrasimod) is an oral, once-daily, 2mg dose medication for adults with moderately to severely
In a company announcement, Biocon informed that it has received a CR (Complete response) letter
